Interleukin-8 and human cancer biology

Cytokine and Growth Factor Reviews

Volumn 12, Issue 4, 2001, Pages 375-391

  Xie, Keping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Interleukin 8; Leukocytes; Pancreatic adenocarcinoma

Indexed keywords

CHEMOTACTIC FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; NITRIC OXIDE;

ACIDOSIS; ANGIOGENESIS; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOSYNTHESIS; CANCER CELL; CANCER GROWTH; CELL DENSITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOLOGY; LEUKOCYTE; METABOLISM; METASTASIS; MITOGENESIS; NEOPLASM; NONHUMAN; PANCREAS ADENOCARCINOMA; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; NEOPLASMS;

EID: 0034849755     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(01)00016-8     Document Type: Review

References (178)

1. Cancer of the pancreas
2. Role of growth factors in pancreatic cancer
3. Advances from genetic clues in pancreatic cancer
4. Experimental animal models for pancreatic cancer
5. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
6. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression
7. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
8. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
9. Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma
10. TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor
11. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
12. Cytokines modulate MIA PaCa-2 and CAPAN-1 adhesion to extracellular matrix proteins
13. Interleukin (IL)-6 as a pancreas carcinoma-derived vascular permeability regulator in vitro
14. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: A possible event in tumor regression
15. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
16. Constitutive and inducible interleukin-8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
17. Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells
18. Cooperation between transcription factor AP-1 and NF-κB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia
19. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma
20. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells
21. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia
22. Cytokine gene expression in B-cell chronic lymphocytic leukemia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
23. Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues
24. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumors
25. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours
26. Characterization of GRO alpha, beta and gamma expression in human colonic tumours: Potential significance of cytokine involvement
27. Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity
28. Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro
29. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
30. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer
31. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
32. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
33. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
34. In vitro differentiation of a Hodgkin's disease derived cell line
35. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells
36. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
37. Spontaneous production of interleukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levels
38. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
39. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
40. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
41. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures
42. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB- and AP-1-dependent mechanism
43. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
44. 4th production of multiple cytokines by cultured human melanomas
45. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells
46. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
47. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load
48. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
49. Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8
50. Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene
51. Regulation of interleukin-8 gene expression by all-trans retinoic acid
52. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines
53. Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma
54. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
55. The chemotactic cytokine interleukin-8 - A cyst fluid marker for malignant epithelial ovarian cancer?
56. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
57. Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter
58. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells
59. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype
60. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
61. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
62. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration
63. IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas
64. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
65. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
66. Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells
67. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
68. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor
69. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor
70. Endothelium-derived factors as paracrine mediators of prostate cancer progression
71. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma
72. Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma
73. Thyroid follicular cells produce interleukin-8
74. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes
75. Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1 alpha stimulation
76. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells
77. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF
78. Interleukin-8: A review
79. Molecular mechanism of interleukin-8 gene expression
80. Interleukin-8 and the chemokine family
81. Regulation of interleukin-8 gene expression
82. Nitric oxide as a secretory product of mammalian cells
83. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression
84. The multifaceted roles of nitric oxide in cancer
85. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
86. Inflammation, immunoregulation, and inducible nitric oxide synthase
87. Role of nitric oxide in tumor progression: Lessons from experimental tumors
88. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates
89. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level
90. Up-regulation of interleukin1beta-stimulated interleukin-8 in human keratinocytes by nitric oxide
91. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-κB binding to DNA: Effects on endothelial function
92. Nitric oxidemediated modulation of interleukin-8 production by a human glioblastoma cell line, T98G, cocultured with myeloid and monocytic cell lines
93. Tumor angiogenesis and tissue factor
94. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
95. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
96. Treatment of cancer with radiation and drugs
97. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
98. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
99. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
100. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
101. Hypoxic induction of interleukin-8 gene expression in human endothelial cells
102. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
103. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-κB activation
104. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: Stimulation of melanoma growth by interleukin-1 and -6
105. Interleukin-8 and melanoma growth-stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines
106. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
107. Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells
108. Regulation of interleukin 8 expression in human malignant melanoma cells
109. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells
110. Regulation of interleukin-8 gene expression by all-trans retinoic acid
111. In vivo human melanoma cytokine production: Inverse correlation of GM-CSF production with tumor depth
112. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma
113. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
114. Changes of cytokines and thyroid function in patients With recurrent breast cancer
115. Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis
116. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
117. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
118. Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells
119. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions
120. Cytokine expression in human primary and metastatic melanoma cells: Analysis in fresh bioptic specimens
121. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load
122. Interleukin-8 immunoreactivity in malignant tumours of the skin
123. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
124. Metastatic potential of human melanoma cells in nude mice-characterisation of phenotype, cytokine secretion and tumour-associated antigens
125. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor
126. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines
127. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
128. Blockade of NF-κB signalling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin-8
129. Hypoxiainduced elevation in interleukin-8 expression by human ovarian carcinoma cells
130. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
131. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor
132. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
133. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
134. A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice
135. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer
136. Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8
137. Interleukin-8 antitumour effect is associated with a local infiltration but not with a systemic activation of T lymphocytes
138. Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity
139. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells
140. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells
141. Interleukin 8: An autocrine growth factor for malignant mesothelioma
142. Interleukin-8 as a macrophage-derived mediator of angiogenesis
143. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth
144. Interleukin-8 stimulates angiogenesis in rats
145. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
146. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
147. In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis
148. Macrophages and angiogenesis
149. The role of cytokines in cancer
150. Mast cells and de novo angiogenesis: Angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF
151. Interleukin-1-alpha and de novo mammalian angiogenesis
152. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
153. Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: Vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8
154. Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8
155. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
156. Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma
157. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
158. Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells
159. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: Predominance of vascular endothelial growth factor
160. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
161. Angiogenesis in normal tissue adjacent to colon cancer
162. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue
163. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata
164. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers
165. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo
166. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
167. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth
168. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8
169. Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro
170. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor
171. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues
172. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane
173. Characterization of two high affinity human interleukin-8 receptors
174. Selectivity and antagonism of chemokine receptors
175. A synthetic peptide inhibitor for alpha-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice
176. Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides
177. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melamona cells in nude mice
178. Level of interleukine-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-κB activity